Hematology-oncology therapy, Volume 487

Front Cover
McGraw-Hill, Medical Pub. Division, 2007 - Medical - 899 pages
0 Reviews
The first clinical manual to bridge the disciplines of hematology and oncology

Hematology-Oncology Therapy integrates an extensive amount of information ( 67 chapters ) that is critical to both office- and hospital-based clinical practice of hematology and oncology. This comprehensive approach makes the book invaluable to all practitioners involved in the care of patients with cancer or hematologic diseases. The three sections of Hematology-Oncology Therapy are

I. Oncology

II. Supportive Care, Drug Preparation, Complications, and Screening

III. Selected Hematologic Diseases

Section I provides detailed information about the administration, emetogenic potential, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens or drugs and biological agents. In addition, each chapter, focused on a specific cancer, contains information about epidemiology, pathology, work-up, and staging, as well as survival data.

Section II consists of topics commonly encountered in clinical hematology-oncology practice. Section III provides an authoritative guide to therapy for the principal diseases in consultative hematology.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Adrenocortical Cancer
1
Anal Cancer
10
Bladder Cancer
20
Copyright

51 other sections not shown

Other editions - View all

Common terms and phrases

About the author (2007)

Tito Fojo, MD
Director of Clinical Research
National Cancer Institute
National Institutes of Health
Bethesda, Maryland

James Frame, MD
Professor of Medicine
University of West Virginia
Director, University of West Virginia Oncology Center
Charleston, West Virginia

Peter Lebowitz, MD
Clinical Fellow
Medical Oncology Clinical Research Unit
National Cancer Institute
National Institutes of Health
Bethesda, Maryland

Michael Boydiazakis, MD
Clinical Fellow
Medical Oncology Clinical Research Unit
National Cancer Institute
Naitonal Institues of Health
Bethesda, Maryland

Dr. Fojo is the research chief at the NCI, and has published over 300 papers on chemotherapy and novel biologic therapies in peer reviewed oncology publications. Dr. Frame is the former chief of the urologic cancer division at the NCI, and has lectured extensively on this topic and others in the realm of solid-tumor oncology.

Bibliographic information